Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms

Por Lehmann, Frederic, Lacombe, Denis, Therasse, Patrick, Eggermont, Alexander MM
Publicado em 2003

International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective

Por Shash, Emad, Negrouk, Anastassia, Marreaud, Sandrine, Golfinopoulos, Vassilis, Lacombe, Denis, Meunier, Francoise
Publicado em 2013

International Rare Cancers Initiative (IRCI)

Por Keat, Nicola, Law, Kate, McConnell, Andrea, Seymour, Matthew, Welch, Jack, Trimble, Ted, Lacombe, Denis, Negrouk, Anastassia
Publicado em 2013

A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054)

Por Rampling, Roy, Sanson, Marc, Gorlia, Thiery, Lacombe, Denis, Lai, Christina, Gharib, Myriam, Taal, Walter, Stoffregen, Clemens, Decker, Rodney, van den Bent, Martin J.
Publicado em 2012

New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III...

Por Gorlia, Thierry, Wu, Wenting, Wang, Meihua, Baumert, Brigitta G., Mehta, Minesh, Buckner, Jan C., Shaw, Edward, Brown, Paul, Stupp, Roger, Galanis, Evanthia, Lacombe, Denis, van den Bent, Martin J.
Publicado em 2013

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

Por Franceschi, Enrico, Stupp, Roger, van den Bent, Martin J., van Herpen, Carla, Laigle Donadey, Florence, Gorlia, Thierry, Hegi, Monika, Lhermitte, Benoit, Strauss, Lewis C., Allgeier, Anouk, Lacombe, Denis, Brandes, Alba A.
Publicado em 2012

Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

Por Raymond, Eric, Brandes, Alba A., Dittrich, Christian, Fumoleau, Pierre, Coudert, Bruno, Clement, Paul M.J., Frenay, Marc, Rampling, Roy, Stupp, Roger, Kros, Johan M., Heinrich, Michael C., Gorlia, Thierry, Lacombe, Denis, van den Bent, Martin J.
Publicado em 2008

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction...

Por Bady, Pierre, Sciuscio, Davide, Diserens, Annie-Claire, Bloch, Jocelyne, van den Bent, Martin J., Marosi, Christine, Dietrich, Pierre-Yves, Weller, Michael, Mariani, Luigi, Heppner, Frank L., Mcdonald, David R., Lacombe, Denis, Stupp, Roger, Delorenzi, Mauro, Hegi, Monika E.
Publicado em 2012

Erratum to: MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding...

Por Bady, Pierre, Sciuscio, Davide, Diserens, Annie-Claire, Bloch, Jocelyne, van den Bent, Martin J., Marosi, Christine, Dietrich, Pierre-Yves, Weller, Michael, Mariani, Luigi, Heppner, Frank L., Macdonald, David R., Lacombe, Denis, Stupp, Roger, Delorenzi, Mauro, Hegi, Monika E.
Publicado em 2013

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Stu...

Por van den Bent, Martin J., Dubbink, Hendrikus J., Sanson, Marc, van der Lee-Haarloo, Cathleen R., Hegi, Monika, Jeuken, Judith W.M., Ibdaih, Ahmed, Brandes, Alba A., Taphoorn, Martin J.B., Frenay, Marc, Lacombe, Denis, Gorlia, Thierry, Dinjens, Winand N.M., Kros, Johan M.
Publicado em 2009

Improving Cancer Outcomes Through International Collaboration in Academic Cancer Treatment Trials

Por Trimble, Edward L., Abrams, Jeffrey S., Meyer, Ralph M., Calvo, Fabien, Cazap, Eduardo, Deye, James, Eisenhauer, Elizabeth, Fitzgerald, Thomas J., Lacombe, Denis, Parmar, Max, Seibel, Nita, Shankar, Lalitha, Swart, Ann Marie, Therasse, Patrick, Vikram, Bhadrasain, von Frenckell, Remy, Friedlander, Michael, Fujiwara, Keiichi, Kaplan, Richard S., Meunier, Francoise
Publicado em 2009

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Por van den Bent, Martin J., Brandes, Alba A., Rampling, Roy, Kouwenhoven, Mathilde C.M., Kros, Johan M., Carpentier, Antoine F., Clement, Paul M., Frenay, Marc, Campone, Mario, Baurain, Jean-Francois, Armand, Jean-Paul, Taphoorn, Martin J.B., Tosoni, Alicia, Kletzl, Heidemarie, Klughammer, Barbara, Lacombe, Denis, Gorlia, Thierry
Publicado em 2009

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951

Por Kouwenhoven, Mathilde C.M., Gorlia, Thierry, Kros, Johan M., Ibdaih, Ahmed, Brandes, Alba A., Bromberg, Jacolien E.C., Mokhtari, Karima, van Duinen, Sjoerd G., Teepen, Johannes L., Wesseling, Pieter, Vandenbos, Fanny, Grisold, Wolfgang, Sipos, László, Mirimanoff, Rene, Vecht, Charles J., Allgeier, Anouk, Lacombe, Denis, van den Bent, Martin J.
Publicado em 2009

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

Por Bogaerts, Jan, Sydes, Matthew R., Keat, Nicola, McConnell, Andrea, Benson, Al, Ho, Alan, Roth, Arnaud, Fortpied, Catherine, Eng, Cathy, Peckitt, Clare, Coens, Corneel, Pettaway, Curtis, Arnold, Dirk, Hall, Emma, Marshall, Ernie, Sclafani, Francesco, Hatcher, Helen, Earl, Helena, Ray-Coquard, Isabelle, Paul, James, Blay, Jean-Yves, Whelan, Jeremy, Panageas, Kathy, Wheatley, Keith, Harrington, Kevin, Licitra, Lisa, Billingham, Lucinda, Hensley, Martee, McCabe, Martin, Patel, Poulam M., Carvajal, Richard, Wilson, Richard, Glynne-Jones, Rob, McWilliams, Rob, Leyvraz, Serge, Rao, Sheela, Nicholson, Steve, Filiaci, Virginia, Negrouk, Anastassia, Lacombe, Denis, Dupont, Elisabeth, Pauporté, Iris, Welch, John J., Law, Kate, Trimble, Ted, Seymour, Matthew
Publicado no Eur J Cancer (2015)

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma: A randomized phase III Intergroup study by EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033)

Por Baumert, Brigitta G., Hegi, Monika E., van den Bent, Martin J., von Deimling, Andreas, Gorlia, Thierry, Hoang-Xuan, Khê, Brandes, Alba A., Kantor, Guy, Taphoorn, Martin J.B., Hassel, Mohamed Ben, Hartmann, Christian, Ryan, Gail, Capper, David, Kros, Johan M., Kurscheid, Sebastian, Wick, Wolfgang, Enting, Roelien, Reni, Michele, Thiessen, Brian, Dhermain, Frederic, Bromberg, Jacoline E., Feuvret, Loic, Reijneveld, Jaap C., Chinot, Olivier, Gijtenbeek, Johanna M. M., Rossiter, John P., Dif, Nicolas, Balana, Carmen, Bravo-Marques, Jose, Clement, Paul M., Marosi, Christine, Tzuk-Shina, Tzahala, Nordal, Robert A., Rees, Jeremy, Lacombe, Denis, Mason, Warren P., Stupp, Roger
Publicado no Lancet Oncol (2016)

Imaging biomarker roadmap for cancer studies

Por O’Connor, James P. B., Aboagye, Eric O., Adams, Judith E., Aerts, Hugo J. W. L., Barrington, Sally F., Beer, Ambros J., Boellaard, Ronald, Bohndiek, Sarah E., Brady, Michael, Brown, Gina, Buckley, David L., Chenevert, Thomas L., Clarke, Laurence P., Collette, Sandra, Cook, Gary J., deSouza, Nandita M., Dickson, John C., Dive, Caroline, Evelhoch, Jeffrey L., Faivre-Finn, Corinne, Gallagher, Ferdia A., Gilbert, Fiona J., Gillies, Robert J., Goh, Vicky, Griffiths, John R., Groves, Ashley M., Halligan, Steve, Harris, Adrian L., Hawkes, David J., Hoekstra, Otto S., Huang, Erich P., Hutton, Brian F., Jackson, Edward F., Jayson, Gordon C., Jones, Andrew, Koh, Dow-Mu, Lacombe, Denis, Lambin, Philippe, Lassau, Nathalie, Leach, Martin O., Lee, Ting-Yim, Leen, Edward L., Lewis, Jason S., Liu, Yan, Lythgoe, Mark F., Manoharan, Prakash, Maxwell, Ross J., Miles, Kenneth A., Morgan, Bruno, Morris, Steve, Ng, Tony, Padhani, Anwar R., Parker, Geoff J. M., Partridge, Mike, Pathak, Arvind P., Peet, Andrew C., Punwani, Shonit, Reynolds, Andrew R., Robinson, Simon P., Shankar, Lalitha K., Sharma, Ricky A., Soloviev, Dmitry, Stroobants, Sigrid, Sullivan, Daniel C., Taylor, Stuart A., Tofts, Paul S., Tozer, Gillian M., van Herk, Marcel, Walker-Samuel, Simon, Wason, James, Williams, Kaye J., Workman, Paul, Yankeelov, Thomas E., Brindle, Kevin M., McShane, Lisa M., Jackson, Alan, Waterton, John C.
Publicado no Nat Rev Clin Oncol (2016)